ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för avibactam. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

20 träffar

Bibliografisk träff 2015-05-29

Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.

Singh R, Kim A, Tanudra MA, Harris JJ, McLaughlin RE, Patey S, O'Donnell JP, Bradford PA, Eakin AE.

J Antimicrob Chemother · research support, non-u.s. gov't; journal article · DOI 10.1093/jac/dkv132

Bibliografisk träff 2015-05-18

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota.

Rashid MU, Rosenborg S, Panagiotidis G, Söderberg-Löfdal K, Weintraub A, Nord CE.

Antimicrob Agents Chemother · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00530-15

Bibliografisk träff 2015-05-11

In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.

Biedenbach DJ, Kazmierczak K, Bouchillon SK, Sahm DF, Bradford PA.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00206-15

Bibliografisk träff 2015-05-08

Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.

Winkler ML, Papp-Wallace KM, Bonomo RA.

J Antimicrob Chemother · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1093/jac/dkv094

Bibliografisk träff 2015-05-01

Safety and pharmacokinetics of single and multiple ascending doses of avibactam alone and in combination with ceftazidime in healthy male volunteers: results of two randomized, placebo-controlled studies.

Merdjan H, Rangaraju M, Tarral A.

Clin Drug Investig · research support, non-u.s. gov't; clinical trial, phase i; randomized controlled trial; journal article · DOI 10.1007/s40261-015-0283-9

Bibliografisk träff 2015-04-20

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.

Rashid MU, Rosenborg S, Panagiotidis G, Löfdal KS, Weintraub A, Nord CE.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2015.02.027

Bibliografisk träff 2015-04-06

Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.

Sader HS, Castanheira M, Mendes RE, Flamm RK, Farrell DJ, Jones RN.

Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/aac.05024-14

Bibliografisk träff 2015-04-06

Ceftazidime-avibactam activity tested against Enterobacteriaceae isolates from U.S. hospitals (2011 to 2013) and characterization of β-lactamase-producing strains.

Castanheira M, Mills JC, Costello SE, Jones RN, Sader HS.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.00163-15

Bibliografisk träff 2015-03-09

Activity of ceftazidime-avibactam against fluoroquinolone-resistant Enterobacteriaceae and Pseudomonas aeruginosa.

Pitart C, Marco F, Keating TA, Nichols WW, Vila J.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.05136-14

Bibliografisk träff 2015-02-17

Avibactam and inhibitor-resistant SHV β-lactamases.

Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.04405-14

Bibliografisk träff 2015-02-17

In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.

Testa R, Cantón R, Giani T, Morosini MI, Nichols WW, Seifert H, Stefanik D, Rossolini GM, Nordmann P.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2014.12.033

Bibliografisk träff 2015-02-14

Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.

Papp-Wallace KM, Bajaksouzian S, Abdelhamed AM, Foster AN, Winkler ML, Gatta JA, Nichols WW, Testa R, Bonomo RA, Jacobs MR.

Diagn Microbiol Infect Dis · research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1016/j.diagmicrobio.2015.02.003

Bibliografisk träff 2015-02-09

Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.

Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA.

Bibliografisk träff 2015-02-02

Pharmacokinetics and penetration of ceftazidime and avibactam into epithelial lining fluid in thigh- and lung-infected mice.

Berkhout J, Melchers MJ, van Mil AC, Seyedmousavi S, Lagarde CM, Nichols WW, Mouton JW.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04627-14

Bibliografisk träff 2015-01-12

In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.

Levasseur P, Girard AM, Miossec C, Pace J, Coleman K.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04218-14

Bibliografisk träff 2014-12-22

In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.

Li H, Estabrook M, Jacoby GA, Nichols WW, Testa RT, Bush K.

Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article · DOI 10.1128/aac.04191-14

Bibliografisk träff 2014-12-08

In vitro activity of ceftazidime-avibactam combination in in vitro checkerboard assays.

Berkhout J, Melchers MJ, van Mil AC, Nichols WW, Mouton JW.

Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04146-14

Bibliografisk träff 2014-12-04

Molecular basis of selective inhibition and slow reversibility of avibactam against class D carbapenemases: a structure-guided study of OXA-24 and OXA-48.

Lahiri SD, Mangani S, Jahić H, Benvenuti M, Durand-Reville TF, De Luca F, Ehmann DE, Rossolini GM, Alm RA, Docquier JD.

ACS Chem Biol · research support, non-u.s. gov't; journal article · DOI 10.1021/cb500703p

Bibliografisk träff 2014-10-31

β-lactam/β-lactamase inhibitor combinations: from then to now.

Toussaint KA, Gallagher JC.

Ann Pharmacother · review; journal article · DOI 10.1177/1060028014556652

Bibliografisk träff 2014-10-25

In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.

Yoshizumi A, Ishii Y, Aoki K, Testa R, Nichols WW, Tateda K.

J Infect Chemother · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jiac.2014.08.028